Urotensin II and Vascular Tone in Cirrhosis

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by Bayside Health.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Bayside Health
ClinicalTrials.gov Identifier:
NCT00163995
First received: September 13, 2005
Last updated: July 25, 2007
Last verified: September 2005
  Purpose

This study looks at the iontophoresis of urotensin II in chronic liver disease patients.


Condition Intervention
Liver Diseases
Cirrhosis
Drug: urotensin II

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Cross-Sectional

Resource links provided by NLM:


Further study details as provided by Bayside Health:

Estimated Enrollment: 40
  Eligibility

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Cirrhosis
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00163995

Contacts
Contact: William W Kemp, MBBS, FRACP 92762000 ext 3327 w.kemp@alfred.org.au

Locations
Australia, Victoria
Alfred Hospital Recruiting
Melbourne, Victoria, Australia, 3181
Contact: William W Kemp, MBBS, FRACP    92762000 ext 3327    w.kemp@alfred.org.au   
Sponsors and Collaborators
Bayside Health
Investigators
Principal Investigator: William W Kemp, MBBS, FRACP The Alfred
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00163995     History of Changes
Other Study ID Numbers: AH4004
Study First Received: September 13, 2005
Last Updated: July 25, 2007
Health Authority: Australia: Human Research Ethics Committee

Keywords provided by Bayside Health:
Chronic Liver Disease

Additional relevant MeSH terms:
Liver Cirrhosis
Fibrosis
Liver Diseases
Digestive System Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on July 29, 2014